BMO Capital raised its price target on Optinose (NASDAQ: OPTN) to $30.00 (from $29.00) while maintaining an Outperform rating.Analyst Gary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE